Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP642133.RAbd9w46qFdUiwtb7PmFvMaKioDMPJxz9O0zF6hq8cJtQ130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642133.RAbd9w46qFdUiwtb7PmFvMaKioDMPJxz9O0zF6hq8cJtQ130_provenance.
• NP864966.RAQr8OCALgNnlm5vguCms_hOQBKh76dxBkU0XEjVBCLNs130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864966.RAQr8OCALgNnlm5vguCms_hOQBKh76dxBkU0XEjVBCLNs130_provenance.
• NP612647.RAVpvAsh8Y4k3DdhyiQ0TIJKcEdu2eNmmUDVWUS9a1c6o130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP612647.RAVpvAsh8Y4k3DdhyiQ0TIJKcEdu2eNmmUDVWUS9a1c6o130_provenance.
• NP975574.RAcKFfPE4wqgDcYe7OArk1brqXQsr7Ro1unmUp-CIumLI130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP975574.RAcKFfPE4wqgDcYe7OArk1brqXQsr7Ro1unmUp-CIumLI130_provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP864235.RAvtwvvwb2YulcW6r_Yf0DxTuJIGYcyVQw8eKFbchJPgg130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP864235.RAvtwvvwb2YulcW6r_Yf0DxTuJIGYcyVQw8eKFbchJPgg130_provenance.
• assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1124461.RAbPmKlkSSZHG5n-MKLEEabbeuxE3iGyCECUuSLpLVtJ0130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124461.RAbPmKlkSSZHG5n-MKLEEabbeuxE3iGyCECUuSLpLVtJ0130_provenance.
• NP1124466.RAZ18hwarDfM0IdTtFKtpCybGvIF7l_rAmmDPuxp50mAA130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124466.RAZ18hwarDfM0IdTtFKtpCybGvIF7l_rAmmDPuxp50mAA130_provenance.
• NP1124470.RARknLs0qiipIYQeyoY9MXoGFMRvgUk80iQIy0m0G9OQc130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124470.RARknLs0qiipIYQeyoY9MXoGFMRvgUk80iQIy0m0G9OQc130_provenance.
• NP1124467.RABNAK9o0vruHM9qTW3omuV_xxPRcbPsBobyxREYLkvoc130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124467.RABNAK9o0vruHM9qTW3omuV_xxPRcbPsBobyxREYLkvoc130_provenance.
• NP1124462.RAg-3_RbedqyPGN4b2etYoB9-FY8jvX1MKAc8mZusyGEo130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124462.RAg-3_RbedqyPGN4b2etYoB9-FY8jvX1MKAc8mZusyGEo130_provenance.
• NP1124465.RAp_ZfNlnZV8u_nicZc6Y6Ql8UsyFpRRMB5-OVJsg0q-8130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124465.RAp_ZfNlnZV8u_nicZc6Y6Ql8UsyFpRRMB5-OVJsg0q-8130_provenance.
• NP1124469.RAgY7DCpcMixu1uDdYuZu6wvQJec2FCc0fs__PGm8z158130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124469.RAgY7DCpcMixu1uDdYuZu6wvQJec2FCc0fs__PGm8z158130_provenance.
• NP1124472.RAvbujF_MYDpKcw-o1Hu2xcKxFJxkE4uTaCccrWq2Rvoo130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124472.RAvbujF_MYDpKcw-o1Hu2xcKxFJxkE4uTaCccrWq2Rvoo130_provenance.
• NP1124473.RAk1IiSzPioev82iUV7HJatWIMK_QX-sOFimD0ke12yeI130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124473.RAk1IiSzPioev82iUV7HJatWIMK_QX-sOFimD0ke12yeI130_provenance.
• NP812944.RAIdUAXoeDwS7OS3ScvW20invra2x7HU3vh2OZfod_WEA130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812944.RAIdUAXoeDwS7OS3ScvW20invra2x7HU3vh2OZfod_WEA130_provenance.
• NP921643.RAEqWaHeJsa_8kg-MmkXIHYPBaDUHlMZUchYshI58NDls130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921643.RAEqWaHeJsa_8kg-MmkXIHYPBaDUHlMZUchYshI58NDls130_provenance.
• NP831781.RA2otIOM1RawsFXcw99SXwN60_p9QX0P2qRQ7RUd54vpI130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831781.RA2otIOM1RawsFXcw99SXwN60_p9QX0P2qRQ7RUd54vpI130_provenance.
• NP1018223.RA8vC-orhYdGsKqcSzzIRqllTKml-Xk-_F52-X6Kq4YyY130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1018223.RA8vC-orhYdGsKqcSzzIRqllTKml-Xk-_F52-X6Kq4YyY130_provenance.
• NP940757.RA_1vmnX5L7xxbxyL_5fmugmF6JoRuT3qHVj6smYam5Fo130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP940757.RA_1vmnX5L7xxbxyL_5fmugmF6JoRuT3qHVj6smYam5Fo130_provenance.
• NP897313.RA4qOePam6V8d6-L8L0lnvPgDcDjv-30rbpOxR9qorWkw130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP897313.RA4qOePam6V8d6-L8L0lnvPgDcDjv-30rbpOxR9qorWkw130_provenance.
• NP1124464.RAz5u2Ir3cQy28J-R6vP32OtCBdCTfJFT3MXmVIaRc_6c130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124464.RAz5u2Ir3cQy28J-R6vP32OtCBdCTfJFT3MXmVIaRc_6c130_provenance.
• NP1124471.RA3HFV7nBhuk0NLhvEnVoKDLeO92QJn-ZPjO4lpBBsQLg130_assertion description "[Malignant melanomas harbouring point mutations (Val600Glu) in the serine/threonine-protein kinase BRAF (BRAF(V600E)) depend on RAF-MEK-ERK signalling for tumour cell growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124471.RA3HFV7nBhuk0NLhvEnVoKDLeO92QJn-ZPjO4lpBBsQLg130_provenance.